SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-107770
Filing Date
2021-04-06
Accepted
2021-04-06 17:25:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d164238ddefa14a.htm DEFA14A 32459
2 GRAPHIC g164238g48q70.jpg GRAPHIC 105634
3 GRAPHIC g164238na3.jpg GRAPHIC 2378
4 GRAPHIC g164238na4.jpg GRAPHIC 2840
5 GRAPHIC g164238na5.jpg GRAPHIC 885
6 GRAPHIC g164238newcontrl.jpg GRAPHIC 13976
  Complete submission text file 0001193125-21-107770.txt   207328
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39782 | Film No.: 21810025
SIC: 2836 Biological Products, (No Diagnostic Substances)